Lilly Sees More Dealmaking as GLP-1 Wins Expand Market
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Learn various ways to cut costs on a limited budget. Make smarter financial choices and save effectively.
21,848 articlesEli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
A provocative claim about a major AI lab and the NSA sparks a broader look at AI safety, governance, and crypto secur...
AI stocks have dazzled markets, but Bill Ackman warns that hype can outrun fundamentals. This guide breaks down the r...
A market dip in the chip sector created a rare buying opportunity. This guide features three thoughtful picks to own ...
A federal appeals court rejects the defenses of Sam Bankman-Fried, upholding a robust fraud conviction. This decision...
Sequoia Capital partner Sean Maguire argues SpaceX sits at a pivotal point similar to Nvidia’s breakout years, and he...
Two bold bets sit at the frontier of transport and connectivity: a space-based mobile network and a next-gen urban ai...
Micron Technology faces a pivotal June 24 earnings moment as AI-driven memory demand tests its growth outlook. A stro...
When a figure headlines with trillionaire status and a big stock sale, investors want to know what it means for the s...
A former social security commissioner argues for higher taxes on the wealthy to shore up Social Security. The idea so...
A software CEO credits AI with tripling her productivity, then her daughter’s Dartmouth essay reveals a personal pers...
Microsoft and Twitter are introducing AI-focused bug bounty programs to surface safety flaws and bias. The move refle...